Cognition Therapeutics, Inc. Shares Outstanding (Cover Page)
Cognition Therapeutics, Inc. (CGTX) had Shares Outstanding (Cover Page) of 95.09 million shares as of 2026-08-04, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-07
- 2026-08-04: Entity Common Stock, Shares Outstanding 95.09M shares.
- 2026-05-05: Entity Common Stock, Shares Outstanding 89.50M shares.
- 2026-03-20: Entity Common Stock, Shares Outstanding 89.35M shares.
- 2025-11-03: Entity Common Stock, Shares Outstanding 88.27M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-04 | 95.09M shares 10-Q · filed 2026-08-07 |
| 2026-05-05 | 89.50M shares 10-Q · filed 2026-05-08 |
| 2026-03-20 | 89.35M shares 10-K · filed 2026-03-26 |
| 2025-11-03 | 88.27M shares 10-Q · filed 2025-11-06 |
| 2025-08-04 | 73.47M shares 10-Q · filed 2025-08-07 |
| 2025-05-05 | 61.99M shares 10-Q · filed 2025-05-07 |
| 2025-03-17 | 61.97M shares 10-K · filed 2025-03-20 |
| 2024-11-08 | 41.55M shares 10-Q · filed 2024-11-13 |
| 2024-08-05 | 40.13M shares 10-Q · filed 2024-08-08 |
| 2024-05-02 | 40.06M shares 10-Q · filed 2024-05-07 |
| 2024-03-22 | 39.00M shares 10-K · filed 2024-03-26 |
| 2023-10-31 | 30.42M shares 10-Q · filed 2023-11-02 |
| 2023-08-04 | 30.31M shares 10-Q · filed 2023-08-08 |
| 2023-05-01 | 29.28M shares 10-Q · filed 2023-05-04 |
| 2023-03-20 | 29.26M shares 10-K · filed 2023-03-23 |
| 2022-11-10 | 23.97M shares 10-Q · filed 2022-11-14 |
| 2022-08-04 | 22.71M shares 10-Q · filed 2022-08-09 |
| 2022-05-05 | 22.60M shares 10-Q · filed 2022-05-11 |
| 2022-03-25 | 22.58M shares 10-K · filed 2022-03-30 |
| 2021-11-17 | 22.04M shares 10-Q · filed 2021-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |